SCHEMBL13601455

SCHEMBL13601455

CCCOC(=O)CCN1CCC(C)CC1

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.42
HRH3 Q9Y5N1 5/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601405 0.91 POLB (0.49) POLBHTTKMT2AALDH1A1HRH3
SCHEMBL13601407 0.88 NAAA (0.47) POLBHTTKMT2AHRH3
SCHEMBL13601396 0.87 POLB (0.54) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL674334 0.86 ALDH1A1 (0.46) SMN1; SMN2KMT2AALDH1A1HRH3KDM4E
SCHEMBL419258 0.86 ALDH1A1 (0.46) SMN1; SMN2KMT2AALDH1A1HRH3KDM4E
SCHEMBL12881361 0.84 GNAI3 (0.47) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL13988123 0.84 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AALDH1A1HRH3TP53
SCHEMBL13601367 0.83 ALDH1A1 (0.41) POLBHTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL420320 0.83 CHRM1 (0.46) POLBSMN1; SMN2KMT2AALDH1A1HRH3
SCHEMBL13601415 0.83 POLB (0.48) POLBHTTSMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed